Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Travis Piper

Podiatrist, Foot Surgery Muskegon, MI Doctor of Podiatric Medicine

NPI 1477519791 CMS profile 248461

561 Seminole Rd, Muskegon, MI 49444

Open in the dashboard

General payments

$5,108

124 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Travis Piper of Muskegon, MI is reported in the CMS Open Payments database as having received $5,108 across 124 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Podiatrist, Foot Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $332 15
2024 General $525 18
2023 General $411 20
2022 General $383 15
2021 General $1,091 21
2020 General $2,012 26
2019 General $354 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Travis Piper
  • Podiatrist, Foot Surgery median
  • Middle half of Podiatrist, Foot Surgery
  • National median

In program year 2025, general payments to Travis Piper were reported at $332. Among 732 Podiatrist, Foot Surgery profiles paid that year, the median was $180 and the middle half received between $70 and $569.

Show as a table
Year Travis Piper Podiatrist, Foot Surgery median Middle half National median
2019 $354 $167 $67–$484 $163
2020 $2,012 $114 $40–$323 $114
2021 $1,091 $171 $57–$502 $132
2022 $383 $196 $66–$556 $149
2023 $411 $187 $78–$466 $160
2024 $525 $190 $78–$557 $164
2025 $332 $180 $70–$569 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Djo, LLC $1,861 80 payments
  2. Wright Medical Technology, Inc. $1,818 14 payments
  3. Paragon 28, Inc. $1,122 15 payments
  4. Stryker Corporation $145 6 payments
  5. Medwest Associates $42 2 payments
  6. DePuy Synthes Sales Inc. $23 1 payment
  7. Davol Inc. $20 1 payment
  8. Treace Medical Concepts, Inc. $17 1 payment
  9. Averitas Pharma Inc. $16 1 payment
  10. Alfasigma USA, Inc. $15 1 payment
  11. Other $29 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $1,980 7 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,796 78 payments
  3. Food and Beverage $1,224 37 payments
  4. Gift $93 1 payment
  5. Education $15 1 payment
Products named General payments · program years 2019–2025
  1. PROstep $1,529 8 payments
  2. PROCARE $1,058 48 payments
  3. Product Portfolio $519 1 payment
  4. AIRCAST Bracing & Supports $317 14 payments
  5. PROCARE Bracing & Supports $317 14 payments
  6. PORTFOLIO $167 1 payment
  7. Bun-Yo-Matic $149 3 payments
  8. MICA $143 3 payments
  9. CANCELLO-PURE $93 1 payment
  10. Precision MIS Bunion $60 1 payment
  11. Other $446 22 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

299

Median for Podiatry: 160

Drug cost

$5,754

Median for Podiatry: $2,368

Branded share of claims

30.4%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Neomycin-Polymyxin-Hc Neomycin/Polymyxin B/Hydrocort Brand 42 $2,249
Ketoconazole Generic 47 $1,507
Terbinafine Hcl Generic 32 $898
Mupirocin Generic 57 $374
Gabapentin Generic 26 $268
Cephalexin Generic 15 $184
Acetaminophen-Codeine Acetaminophen With Codeine Brand 36 $110
Methylprednisolone Generic 11 $69
Prednisone Generic 20 $57
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 13 $39

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 36 billing codes

Paid by Medicare

$57,987

Medicare's payments for the services billed

Medicare patients

251

Average age 76

Services billed

1,054

144 women, 107 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 55%
Diabetes 41%
Chronic kidney disease 37%
Depression 27%
Heart failure 26%
Atrial fibrillation 25%
Ischemic heart disease 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

124 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot Surgery in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record